Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (23)

2023

  1. Development of an Information Guideline for Kidney Transplant Recipients in a Clinical Trial: Protocol for a Modified Delphi Method

    JMIR Research Protocols, Vol. 12, Núm. 1

  2. Fibrillary glomerulonephritis simulating glomerular basal antimembrane antibody disease with associated thrombotic microangiopathy and ANCAp

    Nefrologia

  3. Fibrillary glomerulonephritis simulating glomerular basal antimembrane antibody disease with associated thrombotic microangiopathy and ANCAp

    Nefrologia

2022

  1. Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study

    Clinical transplantation, Vol. 36, Núm. 3, pp. e14550

  2. Severe Acute Kidney Injury Due to Intraglomerular Melanoma: A Case Report

    American Journal of Kidney Diseases, Vol. 80, Núm. 1, pp. 147-150

2020

  1. Effectiveness and safety of the conversion to MeltDose® extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study

    Clinical Transplantation, Vol. 34, Núm. 1

2019

  1. Kidney transplantation from donors after uncontrolled circulatory death: the Spanish experience

    Kidney International, Vol. 95, Núm. 2, pp. 420-428

2017

  1. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey

    Transplant Infectious Disease, Vol. 19, Núm. 6

2013

  1. High incidence of delayed graft function in HIV-infected kidney transplant recipients

    Transplant International, Vol. 26, Núm. 9, pp. 893-902

  2. Once-monthly pegylated epoetin beta versus darbepoetin alfa every two weeks in renal transplant recipients: A randomized Trial

    Transplantation

2012

  1. Anemia control in renal transplant recipients receiving continuous erythropoietin receptor activator (C.E.R.A.) treatment: The AnemiaTrans study

    Advances in Therapy, Vol. 29, Núm. 11, pp. 979-991

  2. Avances en la inmunosupresión para el trasplante renal. Nuevas estrategias para preservar la función renal y reducir el riesgo cardiovascular

    Nefrologia, Vol. 32, Núm. 3, pp. 374-384

2011

  1. Erratum: Estimation of renal allograft half-life: Fact or fiction? (Nephrology Dialysis Transplantation (2011) 26 (30133018) DOI 10.1093/ndt/gfq788)

    Nephrology Dialysis Transplantation

2010

  1. Anemia control in kidney transplant patients treated with methoxy polyethylene glycol-epoetin beta (Mircera): The anemiatrans group

    Transplantation Proceedings, Vol. 42, Núm. 8, pp. 2931-2934

2009

  1. A novel risk score for mortality in renal transplant recipients beyond the first posttransplant year

    Transplantation, Vol. 88, Núm. 6, pp. 803-809

  2. Use of Mycophenolate Sodium in Stable Renal Transplant Recipients in Spain: Preliminary Results of the MIDATA Study

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2309-2312

2008

  1. Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus

    Transplantation, Vol. 86, Núm. 4, pp. 620-622

2007

  1. Early Sirolimus Use With Cyclosporine Elimination Does Not Induce Progressive Proteinuria

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2151-2152

  2. Use of the New Proliferation Signal Inhibitor Everolimus in Renal Transplant Patients in Spain: Preliminary Results of the EVERODATA Registry

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2157-2159

2006

  1. Conversión a sirolimus

    Nefrologia, Vol. 26, Núm. SUPPL.2, pp. 52-63